Invention Grant
- Patent Title: Substituted bicyclic compounds as bromodomain inhibitors
-
Application No.: US15459886Application Date: 2017-03-15
-
Publication No.: US10226451B2Publication Date: 2019-03-12
- Inventor: Shuang Liu , John Frederick Quinn , Bryan Cordell Duffy , Ruifang Wang , May Xiaowu Jiang , Gregory Scott Martin , He Zhao , Michael Ellis , Gregory Steven Wagner , Peter Ronald Young
- Applicant: ZENITH EPIGENETICS LTD
- Applicant Address: CA Calgary, Alberta
- Assignee: Zenith Epigenetics Ltd.
- Current Assignee: Zenith Epigenetics Ltd.
- Current Assignee Address: CA Calgary, Alberta
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K45/06 ; A61K31/4439 ; A61K31/422 ; A61K31/423 ; A61K31/4184 ; C07D405/14 ; C07D403/14 ; C07D405/04 ; C07D417/14 ; C07D471/04 ; A61K31/427 ; C07D413/04 ; C07D413/14 ; A61K31/426 ; A61K31/428 ; A61K31/437 ; A61K31/4725 ; A61K31/496 ; A61K31/497 ; A61K31/4985 ; A61K31/501 ; A61K31/506 ; A61K31/517 ; A61K31/5377 ; A61K31/538 ; C07D409/14 ; C07D487/04 ; A61K31/454
Abstract:
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
Public/Granted literature
- US20170182029A1 NOVEL SUBSTITUTED BICYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS Public/Granted day:2017-06-29
Information query
IPC分类:
